NDC 69681-125

ENTADFI

Finasteride And Tadalafil

ENTADFI is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Veru Inc.. The primary component is Tadalafil; Finasteride.

Product ID69681-125_3a043550-4704-4da9-a3d4-24c198ca7bf6
NDC69681-125
Product TypeHuman Prescription Drug
Proprietary NameENTADFI
Generic NameFinasteride And Tadalafil
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2021-12-12
Marketing CategoryNDA /
Application NumberNDA215423
Labeler NameVeru Inc.
Substance NameTADALAFIL; FINASTERIDE
Active Ingredient Strength5 mg/1; mg/1
Pharm ClassesPhosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA],5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 69681-125-30

30 CAPSULE in 1 BOTTLE (69681-125-30)
Marketing Start Date2021-12-12
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [ENTADFI]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ENTADFI
ENTADFI
90882046 not registered Live/Pending
Veru Inc.
2021-08-13
ENTADFI
ENTADFI
90830745 not registered Live/Pending
Veru Inc.
2021-07-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.